Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Bases de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Hypertension ; 69(6): 1173-1180, 2017 06.
Artigo em Inglês | MEDLINE | ID: mdl-28461600

RESUMO

Elevated levels of myeloperoxidase have been demonstrated in women with preeclampsia where it may contribute to endothelial dysfunction mediated, in part, by nitric oxide impairment. In this study, we investigated myeloperoxidase in hypertensive disorders of pregnancy and its contribution to the impairment of the vasodilator nitric oxide. We found higher levels of myeloperoxidase in supernatant from human umbilical vein endothelial cells cultures incubated with plasma from preeclampsia group compared with healthy pregnant women. Further, we measured plasma concentration and activity of myeloperoxidase in 219 healthy pregnant women, 130 gestational hypertension (on antihypertensive therapy or not), and 143 preeclampsia patients (on antihypertensive therapy or not). We found that patients with preeclampsia and gestational hypertension without antihypertensive treatment showed higher levels and activity of this enzyme, respectively. Moreover, the inhibition of myeloperoxidase activity in vitro improved nitric oxide bioavailability. Our results indicate a higher cardiovascular risk in pregnant women with hypertensive disorders, and that active myeloperoxidase may play a role in endothelial dysfunction in these conditions by impairment of nitric oxide availability. Besides, the use of antihypertensive drugs seems to decrease enzyme levels suggesting a new protective feature for these drugs.


Assuntos
Anti-Hipertensivos/uso terapêutico , Células Endoteliais da Veia Umbilical Humana/metabolismo , Hipertensão Induzida pela Gravidez/sangue , Hipertensão Induzida pela Gravidez/tratamento farmacológico , Óxido Nítrico/sangue , Peroxidase/sangue , Análise de Variância , Biomarcadores/sangue , Estudos de Casos e Controles , Células Cultivadas , Feminino , Idade Gestacional , Células Endoteliais da Veia Umbilical Humana/efeitos dos fármacos , Humanos , Hipertensão Induzida pela Gravidez/diagnóstico , Peroxidase/efeitos dos fármacos , Gravidez , Resultado da Gravidez , Valores de Referência , Estatísticas não Paramétricas
2.
Clin Chim Acta ; 461: 110-3, 2016 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-27496081

RESUMO

BACKGROUND: Several evidences report that a vegetarian diet is protector against cardiovascular diseases. Few studies have demonstrated the circulating profile of cardiovascular biomarkers in vegetarians. Therefore, the aims of the current study were compared the plasma concentrations of myeloperoxidase (MPO), metalloproteinase (MMP)-9, MMP-2, tissue inhibitor of MMP (TIMP)-1 and TIMP-2 between healthy vegetarian (Veg) and healthy omnivorous (Omn). METHODS: Using ELISA and multiplexed bead immunoassay, we measured in plasma from 43 Veg and 41 Omn the cardiovascular biomarkers concentrations cited above. RESULTS: We found significant lower concentrations of MPO, MMP-9, MMP-2 and MMP-9/TIMP-1 ratio in Veg compared to Omn (all P<0.05). Moreover, MMP-9 concentrations were correlated positively with leukocytes and neutrophils count in both groups (all P<0.05). CONCLUSION: A vegetarian diet is associated with a healthier profile of cardiovascular biomarkers compared to omnivorous.


Assuntos
Biomarcadores/sangue , Doenças Cardiovasculares/sangue , Voluntários Saudáveis , Vegetarianos , Dieta , Ensaio de Imunoadsorção Enzimática , Humanos , Imunoensaio , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA